Seminars in Nuclear Medicine

Article	Citations
Letter from the Editors	212
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques	147
Non-FDG hypoxia tracers	88
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update	87
PET/CT in the Imaging of CNS Tumors	87
The Value of FDG PET/CT in Penile Cancer: An Update	83
New Promising Targets for Imaging in Cardiovascular Diseases	65
Imaging of Invasive Fungal Infections- The Role of PET/CT	60
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies	57
FAPI-PET in Cardiovascular Disease	50
Sentinel Lymph Node Methods in Breast Cancer	49
Autoimmune Thyroid Diseases	48
Theranostics in Lung Neuroendocrine Tumors	48
New targets of PET imaging for renal cancer	46
Letter from the Editors	45
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer	43
Imaging for Radiation Planning in Breast Cancer	42
CD70-Targeted Radiotheranostics: Now and Future	38
Artificial Intelligence for Drug Discovery: An Update and Future Prospects	38
The Role of Nuclear Medicine in Benign Thyroid Disease	37
Prognostic Value of PSMA PET/CT in Prostate Cancer	36
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled	36
PET/CT Normal Variants and Pitfalls in Paediatric Disorders	35
Molecular Imaging in Inflammatory Bowel Disease	35
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects	34

Total-Body PET/CT: A Role of Artificial Intelligence?	34
PET-CT radiomics for immunotherapy response	33
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity	33
The evolving role of nuclear medicine in osteomyelitis: A narrative review of current evidence and future horizons	31
Imaging trends in diabetic foot infections	31
Global experience in brain amyloid imaging	31
The Evolution of Artificial Intelligence in Nuclear Medicine	30
Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer	29
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma	28
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects	27
New Approaches for Imaging Bacteria	27
FDG PET for cardiac sarcoidosis: Protocol optimization, quantification, pitfalls, and multimodality imaging integration	27
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects	26
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I	26
Expanding Role for Gallium-68 PET Imaging in Oncology	25
Letter From the Editors	25
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis	25
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology	25
Use of Radionuclide-Based Imaging Methods in Breast Cancer	25
Renography: Methods and Pitfalls	25
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine	24
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices	24
Standardized PSMA-PET Imaging of Advanced Prostate Cancer	24
18F-Fluoride PET/CT—Updates	23
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma	23
Update on Pediatric Nuclear Medicine in Acute Care	23
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging	23
Practical approach to diuretic renography in children: Techniques, interpretation, and pitfalls	23
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases	23
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review	22
Nuclear Medicine Preclinical Research: The Role of Cell Cultures	22
Therapy strategies to defeat prostate cancer heterogeneity	22
FDG PET/CT for Staging Lung Carcinoma: An Update	22
Functional Imaging of Testicular Torsion	21
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview	21
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine	21
Radiolabeled Somatostatin Analogs for Cancer Imaging	21
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?	21
Targeted Radiopharmaceutical Therapy for Bone Metastases	20
The Clinical Utility of Molecular Imaging in COVID-19: An Update	20
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends	20
Letter from the Editors	20
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?	19
The role of nuclear medicine in abdominopelvic infections	19
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma	18
Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature	18
Sentinel Node Mapping in Penile Cancer: An Update on Methods and Pitfalls	18
Artificial Intelligence Augmented Cerebral Nuclear Imaging	18
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET	18
Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma	18

Artificial Intelligence and Workforce Diversity in Nuclear Medicine	17
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)	17
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace	17
Nuclear medicine in paediatric tumours: current status and focus on theranostics.	17
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5	17
Letter From the Guest Editors	16
A Role of Non-FDG Tracers in Lung Cancer?	16
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides	16
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma	16
Prostate Cancer Theranostics With 177Lu-PSMA	16
RETRACTED: Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine	16
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging	15
Neuroimaging of Mild Traumatic Injury	15
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System	15
Advances and challenges of PET imaging in bladder cancer–An update and future trends	15
Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine	15
Cardiac PET/MRI: Recent Developments and Future Aspects	15
The role of cardiac PET imaging in cardiac amyloidosis	15
Letter From the Editors	14
Letter from the Editors	14
Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN)	14
Cardiovascular Imaging in Women	14
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging	14
How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers	14
Letter from the Editors	14
Radiolabeled Antibody–Drug Conjugates in the Treatment of Solid Tumors	14
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence	14
Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce	13
Letter from the Editors	13
Response assessment in advanced differentiated thyroid cancer	13
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases	13
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational	13
Total Body PET/CT: A Role in Musculoskeletal Diseases	13
Preclinical Evaluation of Novel PET Probes for Dementia	13
Positron emission tomography imaging of inflammation and infection in children: an update	13
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy	13
PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis	13
Parathyroid Imaging	13
Letter From the Editors	13
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update	12
Radiopharmaceuticals for imaging T-cells	12
New Targets for Imaging in Nuclear Medicine	12
Insights into the Global Practice of Paediatric Renal Scintigraphy Studies	12
Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[18F]FDG-PET/CT, 18F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone	12
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer	12
Current status on imaging invasive fungal infections with positron emission tomography	12
Letter from the Editors	12
FDG PET/CT for Staging and Restaging Malignant Mesothelioma	12
Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging	12
PET imaging of polymyalgia rheumatica: update and future trends	11
New Targets for Positron Emission Tomography Imaging in Parkinson´s Disease	11
Rare subcutaneous metastases of papillary thyroid carcinoma revealed by 18F-FDG PET/CT	11
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?	11
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update	11
The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update	11
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies	11
Current and Future Perspectives of PDL1 PET and SPECT Imaging	10
AI in SPECT Imaging: Opportunities and Challenges	10
Glypican-3: Novel Theranostic Agent for Hepatocellular Carcinoma	10
Imaging of Bone Metastases in Breast Cancer	10
Imaging of infection in Nephro-urology: A practical nuclear medicine–focused review	10
Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access	10
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review	10
Equine nuclear medicine: Current state of play	9
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers	9
Imaging Approach to Disease of the Pleura	9
Application of Deep Learning in Breast Cancer Imaging	9
Can AI Make Paediatric PET/CT Lower Dose? Opportunities, Evidence and Cautions	9
Standardization of infection [18F]FDG-PET/CT imaging protocols and reporting criteria	9
Letter from the Editors	9
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer	9
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma	9
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?	9
Letter From the Editors	9
Molecular imaging Theranostics of Neuroendocrine Tumors	9
FDG PET/CT Imaging of Sarcoidosis	9
Advances in PSMA Alpha Theragnostics	9
Combination Strategies and Targeted Radionuclide Therapies	9
Quantification, radiomics and artificial intelligence in infection imaging: Current status and future directions in nuclear medicine	9
Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain	9

Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review	8
Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends	8
New targets for PET imaging of inflammation	8
FAP in cardiovascular pathophysiology: Advances in non-invasive imaging and therapeutic targeting for myocardial fibrosis	8
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma	8
The Current Role of Tau PET Imaging in Neurodegeneration	8
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging	8
Letter From the Editors	8
Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer	8
Updates on tuberculosis imaging	8
Re-defining the 3Rs of pre-clinical research in nuclear medicine	8
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer	8
Molecular Imaging of Tuberculosis	8
Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care	8
Total Body PET-CT Protocols in Oncology	7
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma	7
Mucin-Targeted Antibodies for Ovarian Cancer	7
Present status and future trends in molecular imaging of lymphocytes	7
18F-FDG PET/CT for Response Assessment in Lung Cancer	7
The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art	7
The Role of FAPI PET/CT in the Assessment of Inflammatory Diseases	7
How to Report PSMA PET	7
Clinical implementation of RECIP 1.0	7
Vulnerable Plaque Imaging	7
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies	7
Molecular Imaging of Fever of Unknown Origin: An Update	7
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update	7
Renal Scintigraphy in Adults: An Update	7
The role of non-FDG agents in PET imaging of bladder cancer	7
The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer	7
Molecular Imaging of Pituitary Tumors	7